PSC
CRSP icon

Prentiss Smith & Co’s CRISPR Therapeutics CRSP Stock Holding History

Prentiss Smith & Co’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,464
Closed -$237K – 76
2021
Q2 		$237K Buy
+1,464
New +$237K 0.11% 72